IZBA

novartis pharmaceuticals canada inc🇨🇦 Health Canada

Approval Id: 14fab902fcb5ea9d
Drug Approval Canada Name: IZBA
Product Name: IZBA
Status: Marketed
Status Date: 2018-04-03
Original Market Date: 2017-02-06
Din: 02457997
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Ophthalmic
Schedule: Prescription
Ahfs: 52:40.28
Atc Original: S01EE04 TRAVOPROST
Atc Name: s 01 ee 04
Aig Number: 0145801002
Company Name: novartis pharmaceuticals canada inc
Company Address: 100, 700 Rue Saint-Hubert, Montreal, Quebec, Canada, H2Y 0C1

TRAVOPROST

0.003 % / W/V

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

14fab902fcb5ea9d

Type

Standard